A publication in Nature in April 2026 reports that N-desethyl-fluornitrazene (DFNZ), a modified nitazene and µ-opioid receptor (MOR) superagonist, produced potent analgesia in rodents with less respi… [+4610 chars]
Read Full Story
- Home
- Kenya News
- How the opioid superagonist DFNZ challenges pain medicine
Related Post
Russia doubles wheat exports to African country
Russian wheat shipments to Sudan have more than doubled, the Russian agriculture export agency Agroexport said on Tuesday. Exporters delivered…
World must jointly tackle issues of climate change, pollution, UN says
The world needs a new approach to environmental crises threatening the health of people and the planet by adopting policies…
Volcanoes can help us untangle the evolution of humans – here’s how
NASA’s Earth Observatory How did humans become human? Understanding when, where and in what environmental conditions our early ancestors lived…
Nehru’s India: a history in seven myths
Sherman, Taylor C. (2022) Nehru’s India: a history in seven myths. Princeton University Press. ISBN 9780691222585 Full text not available…
Consumer Loyalty Business Databook Report 2026: Market Size & Forecast by Spend Value Across 100+ KPIs by Program Type, Channel Mix, Sector, Embedded Loyalty Penetration, and Platform Spend 2021-2030
Dublin, Feb. 06, 2026 (GLOBE NEWSWIRE) — The “Loyalty Market Size & Forecast by Spend Value Across 100+ KPIs by…